As a side note, I did add today and will hold this level for some time. I do believe Sony has to start getting their investment back sooner rather than later.
Sony is the key and Tokman is Tokman. Why would he consider shareholders at this point in our travels? Although it is up to our customers to announce there is nothing prohibiting MVIS from keeping us informed as to the progress being made on the laser front and the power and size fronts. I have always questioned Tokmans abilities and will never understand his reluctance to provide investors decent information to attract additional or new investment here. I also don't think he gives a dam as we approach the ASM and don't really look for anything we don't already know. Tokman is Tokman.
Well gentlemen, I did my best with the CES up dates as I received reports. I hope you will do the same and give us some of your deep thoughts on what you see and hear at the ASM.
Exactly, those are questions we deserve answers to or at least a better explanation from management. They don't mind asking for more shares for their performance. They should at least give us some insight as to why they deserve those perks with a little guidance on those issues you boys have brought up.
is needed to be seen by retail investors on the partnership side. You just can't keep handing the bills to the few who have kept this company afloat for the past several years. I have held bios in the past and they have done a great job of partnering and easing the load on investors. Dr. Kim stated partnerships were a prime goal of INO and yet he lost half of the only one we had. Today's post by VJ made it crystal clear that shareholders can expect more dilution by the company. For all the active indications we have going and the huge pipeline we have there has to be some relief that investors can see besides government subsidies. Without partnerships from big pharma, we can't even sell approved vaccines. It costs a fortune to develop a first rate sales staff and build from the ground up alone. It looks as if Mr. Hertels emal to VJ just opened some eyes as to just how long this is going to flounder with dilution always hanging over the company. Dr. Kim's failure to attract big pharma is his biggest flaw. The facebook, go it alone crowd, don't have a clue about the costs associated with going it alone. Just look at the number of posts VJ has under that heading. Tells a much bigger story.
I guess I'm old fashioned, I believe incentives should be performance based. When they can guide forward on earnings and profitability I can see a reason to award incentives. I cringe at awarding anything on "first and goal, shipping to the first of three" etc, etc. No disputing the fact that Sony is aboard and we are looking good and most of us are loaded right here, but I want to see him finish just once. Then we can talk about incentives for the team.
I had no difficulty voting no. They helped themselves to an 8 for 1 in 2012 as everybody knows and since then have given us a lot of hope and anguish. Things never looked better, but until they can forecast earnings and move the pps for us they can wait for additional dilution to fill their pockets. They have the votes to push it through as Bull2 says, but we retail, bill paying members of this exclusive club should let them know they have to start considering us. Even their timing on issues seems to discount shareholders over and over. Send a message.
Ten years here and we still have to guess at what management is doing while handing us the bills.
Stop it, just stop it. It wasn't than long ago, a few years back when all the longs and pumpers were saying,"Just one big name is all it is going to take and this stock is $20". I'm not saying it won't get there, but an 8 year deal with one of the biggest and best names is worth three bucks. A fifty percent move from where we were with the shorts in control of the whole shebang. I would just like to see Tokman keep us in mind just once as he finances his way to success on our backs. And get a load of proposal
#2, robbery. I believe they can wait until they start to pay back the folks that have paid all the bills so far. Wake up folks, we haven't earned any ones respect yet, but Sony's.
No, I didn't mean $2 even. I don't see it going much lower in any case and that is why I purchased more. Gotta move when the tide is right and it is on its way in. I look for news soon as I feel there are more in the pipeline than Sony so this could be the year for us. I hate to predict pps at end of year and all that #$%$, I have been wrong to often, but I do feel pretty secure holding this now, more so than ever before. Can't stop the shorts from banging away until the management decides to play with the folks that have kept the doors open, us. That will come, I just don't know when.
They won't give it, they don't have it. He has lost his mojo. All momentum shot on dwarfing. Nothing here but Rah Rah early investors with blinders on. Dilution was poorly timed unless he knows what the Peer Review says. Too much like the RS in advance of the P2. Decent data, but way short of the Street expectations and they were high on Dr. KIm's pumping. He has a long way to go to get the attention he had and the power in what he has to say now.JMHO
Already did. Looking for something newer than the same year old data. I didn't think the CC would reveal anything new and apparently I was right as the pps indicates. Agony watching Kim perform, nothing like the Dr. Kim of 2014. Big question is why we can't get a partnership or two?
Have they said anything in the CC about Peer Review? Seems like it is taking a very long time. Has Dr. Kim unleashed any cute phrasing for this years performance? Anybody listening to the CC?